Clinical Trial Update: Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Metarrestin (ML-246) in subjects with metastatic solid tumors; the study is currently recruiting across multiple indications i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Malignant Peripheral Nerve Sheath Tumor
• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• Metarrestin (ML-246)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Solid Tumors, Metastatic Pancreatic Cancer | Phase 1 | Status: RECRUITING